{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T01:11:53Z","timestamp":1772932313584,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jamda.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.jamda.2015.05.012","type":"journal-article","created":{"date-parts":[[2015,6,30]],"date-time":"2015-06-30T09:32:00Z","timestamp":1435656720000},"page":"969-972","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Treatment of Nonagenarians With Atrial Fibrillation: Insights From the Berlin Atrial Fibrillation (BAF) Registry"],"prefix":"10.1016","volume":"16","author":[{"given":"Alexander","family":"Wutzler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"von Ulmenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Attanasio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Huemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul Shokor","family":"Parwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leif-Hendrik","family":"Boldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilhelm","family":"Haverkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2015.05.012_bib1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: A global Burden of disease 2010 study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jamda.2015.05.012_bib2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1378\/chest.14-0321","article-title":"Prevalence, incidence, and lifetime risk of atrial fibrillation in China: New insights into the global burden of atrial fibrillation","volume":"147","author":"Guo","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.jamda.2015.05.012_bib3","first-page":"w14059","article-title":"General management of nonagenarian patients: A review of the literature","volume":"144","author":"Rivoirard","year":"2014","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.jamda.2015.05.012_bib4","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1001\/jamainternmed.2014.4758","article-title":"Underrepresentation of women, elderly patients, and racial minorities in the randomized trials used for cardiovascular guidelines","volume":"174","author":"Sardar","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jamda.2015.05.012_bib5","doi-asserted-by":"crossref","first-page":"e0119043","DOI":"10.1371\/journal.pone.0119043","article-title":"Comorbidities against quality control of VKA therapy in non-valvular atrial fibrillation: A French national cross-sectional study","volume":"10","author":"Rouaud","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jamda.2015.05.012_bib6","first-page":"281","article-title":"Direct treatment cost of atrial fibrillation in the elderly American population: A Medicare perspective","volume":"11","author":"Lee","year":"2008","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.jamda.2015.05.012_bib7","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/europace\/euq350","article-title":"ESC Committee for Practice Guidelines. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"12","author":"Camm","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.jamda.2015.05.012_bib8","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A\u00a0novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jamda.2015.05.012_bib9","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2165\/11591680-000000000-00000","article-title":"Is antiarrhythmic treatment in the elderly different? A review of the specific changes","volume":"28","author":"Deneer","year":"2011","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jamda.2015.05.012_bib10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cger.2012.07.001","article-title":"Pharmacology of antiarrhythmic drugs in elderly patients","volume":"28","author":"Frishman","year":"2012","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.jamda.2015.05.012_bib11","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0735-1097(98)00561-0","article-title":"Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise. A crossover open-label study of five drug regimens","volume":"33","author":"Farshi","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jamda.2015.05.012_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0735-1097(00)00693-8","article-title":"Use of metoprolol CR\/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: A randomized, double-blind, placebo-controlled study","volume":"36","author":"K\u00fchlkamp","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jamda.2015.05.012_bib13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jamda.2015.05.012_bib14","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jacc.2010.05.028","article-title":"Age as a risk factor for stroke in atrial fibrillation patients: Implications for thromboprophylaxis","volume":"56","author":"Marinigh","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jamda.2015.05.012_bib15","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1093\/eurheartj\/ehu046","article-title":"Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: Observations from the ARISTOTLE trial","volume":"35","author":"Halvorsen","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jamda.2015.05.012_bib16","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1161\/STROKEAHA.108.526988","article-title":"Effect of age on stroke prevention therapy in patients with atrial fibrillation: The atrial fibrillation investigators","volume":"40","author":"van Walraven","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.jamda.2015.05.012_bib17","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/ageing\/afr097","article-title":"Attitudes of physicians regarding anticoagulation for atrial fibrillation: A systematic review","volume":"40","author":"Pugh","year":"2011","journal-title":"Age Ageing"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861015003795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861015003795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T07:55:02Z","timestamp":1537516502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861015003795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":17,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S1525861015003795"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2015.05.012","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Nonagenarians With Atrial Fibrillation: Insights From the Berlin Atrial Fibrillation (BAF) Registry","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2015.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 AMDA \u2013 The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}